| Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 791 | 2009 |
| Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis PS Sorensen, C Ross, KM Clemmesen, K Bendtzen, JL Frederiksen, ... The Lancet 362 (9391), 1184-1191, 2003 | 446 | 2003 |
| Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring L Kappos, D Bates, G Edan, M Eraksoy, A Garcia-Merino, N Grigoriadis, ... The Lancet Neurology 10 (8), 745-758, 2011 | 375 | 2011 |
| Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis PS Sorensen, B Wanscher, CV Jensen, K Schreiber, M Blinkenberg, ... Neurology 50 (5), 1273-1281, 1998 | 369 | 1998 |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 344 | 2018 |
| Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring L Kappos, D Bates, HP Hartung, E Havrdova, D Miller, CH Polman, ... The Lancet Neurology 6 (5), 431-441, 2007 | 259 | 2007 |
| Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS M Blinkenberg, K Rune, CV Jensen, M Ravnborg, S Kyllingsbæk, S Holm, ... Neurology 54 (3), 558-558, 2000 | 198 | 2000 |
| Effects of neuropsychological treatment in patients with multiple sclerosis A Jønsson, EM Korfitzen, A Heltberg, MH Ravnborg, E Byskov‐Ottosen Acta Neurologica Scandinavica 88 (6), 394-400, 1993 | 170 | 1993 |
| Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis J Rønager, M Ravnborg, I Hermansen, S Vorstrup Artificial organs 25 (12), 967-973, 2001 | 168 | 2001 |
| Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients PS Sorensen, N Koch-Henriksen, T Petersen, M Ravnborg, A Oturai, ... Journal of Neurology 261, 1170-1177, 2014 | 159 | 2014 |
| Post-activation depression of soleus stretch reflexes in healthy and spastic humans MJ Grey, K Klinge, C Crone, J Lorentzen, F Biering-Sørensen, ... Experimental Brain Research 185, 189-197, 2008 | 152 | 2008 |
| The six spot step test: a new measurement for walking ability in multiple sclerosis MM Nieuwenhuis, H Van Tongeren, PS Sørensen, M Ravnborg Multiple Sclerosis Journal 12 (4), 495-500, 2006 | 146 | 2006 |
| IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS P Soelberg Sorensen, J Haas, F Sellebjerg, T Olsson, M Ravnborg, ... Neurology 63 (11), 2028-2033, 2004 | 135 | 2004 |
| Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome G Comi, V Martinelli, M Rodegher, L Moiola, L Leocani, O Bajenaru, ... Multiple Sclerosis Journal 19 (8), 1074-1083, 2013 | 131 | 2013 |
| A randomized study of two interferon-beta treatments in relapsing–remitting multiple sclerosis N Koch-Henriksen, PS Sørensen, T Christensen, J Frederiksen, ... Neurology 66 (7), 1056-1060, 2006 | 122 | 2006 |
| 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review HB Jensen, M Ravnborg, U Dalgas, E Stenager Therapeutic advances in neurological disorders 7 (2), 97-113, 2014 | 120 | 2014 |
| Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study A Jønsson, J Andresen, L Storr, T Tscherning, PS Sørensen, M Ravnborg Journal of the neurological sciences 245 (1-2), 77-85, 2006 | 117 | 2006 |
| Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients T Sejbaek, HH Nielsen, N Penner, T Plavina, JP Mendoza, NA Martin, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (12), 1324-1330, 2019 | 110 | 2019 |
| Effect of baclofen on gait in spastic MS patients. GB Ørsnes, PS Sørensen, TK Larsen, M Ravnborg Acta neurologica scandinavica 101 (4), 2000 | 106 | 2000 |
| Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis A Jønsson, J Dock, MH Ravnborg Acta Neurologica Scandinavica 93 (4), 229-235, 1996 | 104 | 1996 |
